Regenerative Medicine Institute (REMEDI)
REMEDI’s vision is to develop a new and realizable paradigm for medicine in the future utilizing minimally invasive therapeutic approaches to promote organ and tissue repair and regeneration thus avoiding the need for replacement. To achieve this, the REMEDI translational research programme has a mission to conduct basic research in fundamental stem cell biology and to translate and commercialise research outputs by developing regenerative medicine therapies for diseases such as; cardiovascular disease, diabetes mellitus and osteoarthritis. Supporting the realization of our vision are the strategic partnerships REMEDI has forged with academics, the health service and industry.
“REMEDI is a world-class biomedical research institute with a central focus on conducting basic and applied research in regenerative medicine, an emerging field that combines the technologies of gene therapy, adult stem cell therapy, biomaterials science and clinical medicine.”
Our Research Areas
The aim of this programme is to develop novel stem cell based therapeutics for osteoarthritis and cartilage repair.
Gene Therapy entails the delivery of new genetic information to cells so that their function is altered.
The aim of this programme is to develop novel therapeutic approaches for the treatment of atherosclerotic vascular diseases.